Delayed awakening from general anaesthesia in a patient with Hunter syndrome

Alan Kreidstein, Martin R. Boorin, Paul Crespi, Philip W. Lebowitz, Samuel Barst

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Hunter syndrome is one of a heterogeneous group of recessively inherited mucopolysaccharide storage diseases (MPS) with similar biochemical defects manifested by impairments in muco-polysaccharide catabolism with variable but progressive clinical courses. Abnormal accumulation and deposition of mucopoly-saccharides in the tissues of several organs lead to numerous anatomical, musculoskeletal and neurological abnormalities which are known to complicate anaesthetic and airway management. Hunter syndrome has a wide variance of clinical phenotypes ranging from mild to severe. We present a patient having physical and neurological features consistent with a severe clinical presentation of Hunter syndrome (MPS, Type II). Following a seemingly uneventful intraoperative anaesthetic course including isoflurane, nitrous oxide and fentanyl (0.93 μg · kg-1), resumption of spontaneous ventilation and return to consciousness were delayed until intravenous naloxone (200 μg) was administered 100 min after the opioid administration. The cause of delayed recovery from anaesthesia in this patient is unknown.

Original languageEnglish (US)
Pages (from-to)423-426
Number of pages4
JournalCanadian Journal of Anaesthesia
Volume41
Issue number5
DOIs
StatePublished - May 1994

Fingerprint

Delayed Emergence from Anesthesia
Mucopolysaccharidosis II
General Anesthesia
Anesthetics
Musculoskeletal Abnormalities
Airway Management
Isoflurane
Nitrous Oxide
Fentanyl
Naloxone
Glycosaminoglycans
Consciousness
Opioid Analgesics
Polysaccharides
Ventilation
Phenotype

Keywords

  • anaesthesia: paediatric
  • analgesics: fentanyl
  • syndromes: mucopolysaccharidoses
  • ventilation: anaesthetics, effects of

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Delayed awakening from general anaesthesia in a patient with Hunter syndrome. / Kreidstein, Alan; Boorin, Martin R.; Crespi, Paul; Lebowitz, Philip W.; Barst, Samuel.

In: Canadian Journal of Anaesthesia, Vol. 41, No. 5, 05.1994, p. 423-426.

Research output: Contribution to journalArticle

Kreidstein, Alan ; Boorin, Martin R. ; Crespi, Paul ; Lebowitz, Philip W. ; Barst, Samuel. / Delayed awakening from general anaesthesia in a patient with Hunter syndrome. In: Canadian Journal of Anaesthesia. 1994 ; Vol. 41, No. 5. pp. 423-426.
@article{0125a31240904ebdba64e600092b534a,
title = "Delayed awakening from general anaesthesia in a patient with Hunter syndrome",
abstract = "Hunter syndrome is one of a heterogeneous group of recessively inherited mucopolysaccharide storage diseases (MPS) with similar biochemical defects manifested by impairments in muco-polysaccharide catabolism with variable but progressive clinical courses. Abnormal accumulation and deposition of mucopoly-saccharides in the tissues of several organs lead to numerous anatomical, musculoskeletal and neurological abnormalities which are known to complicate anaesthetic and airway management. Hunter syndrome has a wide variance of clinical phenotypes ranging from mild to severe. We present a patient having physical and neurological features consistent with a severe clinical presentation of Hunter syndrome (MPS, Type II). Following a seemingly uneventful intraoperative anaesthetic course including isoflurane, nitrous oxide and fentanyl (0.93 μg · kg-1), resumption of spontaneous ventilation and return to consciousness were delayed until intravenous naloxone (200 μg) was administered 100 min after the opioid administration. The cause of delayed recovery from anaesthesia in this patient is unknown.",
keywords = "anaesthesia: paediatric, analgesics: fentanyl, syndromes: mucopolysaccharidoses, ventilation: anaesthetics, effects of",
author = "Alan Kreidstein and Boorin, {Martin R.} and Paul Crespi and Lebowitz, {Philip W.} and Samuel Barst",
year = "1994",
month = "5",
doi = "10.1007/BF03009866",
language = "English (US)",
volume = "41",
pages = "423--426",
journal = "Canadian Anaesthetists Society Journal",
issn = "0832-610X",
publisher = "Canadian Anaesthetists Society",
number = "5",

}

TY - JOUR

T1 - Delayed awakening from general anaesthesia in a patient with Hunter syndrome

AU - Kreidstein, Alan

AU - Boorin, Martin R.

AU - Crespi, Paul

AU - Lebowitz, Philip W.

AU - Barst, Samuel

PY - 1994/5

Y1 - 1994/5

N2 - Hunter syndrome is one of a heterogeneous group of recessively inherited mucopolysaccharide storage diseases (MPS) with similar biochemical defects manifested by impairments in muco-polysaccharide catabolism with variable but progressive clinical courses. Abnormal accumulation and deposition of mucopoly-saccharides in the tissues of several organs lead to numerous anatomical, musculoskeletal and neurological abnormalities which are known to complicate anaesthetic and airway management. Hunter syndrome has a wide variance of clinical phenotypes ranging from mild to severe. We present a patient having physical and neurological features consistent with a severe clinical presentation of Hunter syndrome (MPS, Type II). Following a seemingly uneventful intraoperative anaesthetic course including isoflurane, nitrous oxide and fentanyl (0.93 μg · kg-1), resumption of spontaneous ventilation and return to consciousness were delayed until intravenous naloxone (200 μg) was administered 100 min after the opioid administration. The cause of delayed recovery from anaesthesia in this patient is unknown.

AB - Hunter syndrome is one of a heterogeneous group of recessively inherited mucopolysaccharide storage diseases (MPS) with similar biochemical defects manifested by impairments in muco-polysaccharide catabolism with variable but progressive clinical courses. Abnormal accumulation and deposition of mucopoly-saccharides in the tissues of several organs lead to numerous anatomical, musculoskeletal and neurological abnormalities which are known to complicate anaesthetic and airway management. Hunter syndrome has a wide variance of clinical phenotypes ranging from mild to severe. We present a patient having physical and neurological features consistent with a severe clinical presentation of Hunter syndrome (MPS, Type II). Following a seemingly uneventful intraoperative anaesthetic course including isoflurane, nitrous oxide and fentanyl (0.93 μg · kg-1), resumption of spontaneous ventilation and return to consciousness were delayed until intravenous naloxone (200 μg) was administered 100 min after the opioid administration. The cause of delayed recovery from anaesthesia in this patient is unknown.

KW - anaesthesia: paediatric

KW - analgesics: fentanyl

KW - syndromes: mucopolysaccharidoses

KW - ventilation: anaesthetics, effects of

UR - http://www.scopus.com/inward/record.url?scp=0028233876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028233876&partnerID=8YFLogxK

U2 - 10.1007/BF03009866

DO - 10.1007/BF03009866

M3 - Article

VL - 41

SP - 423

EP - 426

JO - Canadian Anaesthetists Society Journal

JF - Canadian Anaesthetists Society Journal

SN - 0832-610X

IS - 5

ER -